Clinical trials
Phase 2 Cognitive Dysfunction trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aelis Farma | 1 |
| Araclon Biotech S.L. | 1 |
| Biogen | 1 |
| Hovid Berhad | 1 |
| Inmune Bio, Inc. | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Ipsen | 1 |
| Janssen Research & Development, LLC | 1 |
| University Hospital, Lille | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 11 |
| Alzheimer Disease | 6 |
| Dementia | 3 |
| Stroke | 2 |
| Brain Diseases | 1 |
| CADASIL | 1 |
| Central Nervous System Diseases | 1 |
| Cerebral Small Vessel Diseases | 1 |
| Cerebrovascular Disorders | 1 |
| Down Syndrome | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.